Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. [electronic resource]
Producer: 20120328Description: 574-85 p. digitalISSN:- 1555-8576
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Line, Tumor
- Ceramides -- administration & dosage
- Deoxycytidine -- administration & dosage
- Drug Carriers -- therapeutic use
- Drug Resistance, Neoplasm
- Drug Synergism
- Enzyme Inhibitors -- pharmacology
- Female
- Glucosyltransferases -- antagonists & inhibitors
- Humans
- Liposomes -- therapeutic use
- MAP Kinase Signaling System -- drug effects
- Mice
- Mice, Nude
- Morpholines -- administration & dosage
- Nanoparticles -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.